Patents by Inventor André Capron

André Capron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bordetella strain expressing the FHA hybrid, liposomes and vaccines
    Patent number: 6660261
    Abstract: The invention concerns a Bordetella strain deficient in the production of toxin and expressing a hybrid protein comprising at least part of the filamentous hemagglutin (FHA) and at least part of a protein heterologous to FHA. The gene coding for the toxin has been eliminated, or at least partially deleted or mutated so as to produce an inactive toxin. This strain can be used as vaccine. The invention also concerns liposomes containing at least part of the FHA protein and at least one protein heterologous to the FHA protein, and the use of FHA for the stimulation of immune responses.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: December 9, 2003
    Assignee: Institut Pasteur de Lille
    Inventors: Nathalie Mielcarek, Camille Locht, Gilles Riveau, Odile Poulain-Godefroy, André Capron
  • Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications
    Patent number: 6392014
    Abstract: The invention relates to cloning of the gene for the toxoplasma GP28.5 antigen. It also encompasses purified GP28.5 antigen preparations and antigenic polypeptides derived from said antigen, and their applications.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: May 21, 2002
    Inventors: Marie-France Cesbron, Corinne Mercier, André Capron, André Tartar, Pierrette Maes